To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Environment.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H0D63C2F8C226478BAE5D3CACAA22BEE0: 1. Short title This Act may be cited as the Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023.
- Section H1DE83F05CCC24B04AE7DF111349BBA14: 2. Findings The Congress finds as follows: Menstrual products and intimate care products are widely used in the United States today, but there is not enough...
- Section H96E86F7F74C342508907ED3ACBBB4FC5: 3. Research on dioxins and other potentially harmful components of menstrual products and intimate care products Part F of title IV of the Public Health...
- Section HE81EEA1F1FEA450E8B1D1EACB0954A30: 486C. Research on dioxins and other potentially harmful components of menstrual products and intimate care products The Director of NIH shall provide for the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Environment
Primary Purpose
This bill, To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the Committee on Energy and Commerce
Ms. Meng (for herself, Mr. Khanna, Ms. Chu, Mrs. Watson …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
Key Definitions
Terms defined in this bill
tampons, pads, liners, cups, sponges, and similar products used by people who menstruate with respect to menstruation or other genital-tract secretions
tampons, pads, liners, cups, sponges, and similar products used by people who menstruate with respect to menstruation or other genital-tract secretions
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology